Slovenia – Pharmaceutical products – NAKUP ZDRAVIL - POZIV2

Univerzitetni Klinični Center Ljubljana · Slovenia government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$90.8M
Est. Value
Active
Status

Opportunity Overview

aflibercept, napolnjena injekcijska brizga, 0,165 ml | aflibercept, napolnjena injekcijska brizga, 0,09 ml | BCG cepivo proti tuberkulozi za intravezikalno uporabo, ne manj kot 300 miljonov živih BCG na 1 vialo oz. 3.000.000.000 CFU na vialo | beremagen geperpavek, 5000000000 PFU / 1 ml | bevacizumab, 25 mg / 1 ml 70% | ceftazidim + avibaktam, (2 g + 0,5 g) / 1 viala | cilastatin + imipenem + relebaktam, (500 mg + 500 mg + 250 mg) / 1 vialo | dinutuksimab beta, 4,5 mg / 1 ml | efgartigimod alfa, 20 mg / 1 ml | faricimab, 120 mg / 1 ml | folitropin alfa, 450 i.e. / 0,72 ml | folitropin alfa, 900 i.e. / 1,44 ml | fosamilceftarolin, 600 mg / 1 viala | glukarpidaza, 1000 e. / 1 viala | inebilizumab, 100 mg / 1 ml | inklisiran, 284 mg / 1 brizga | karmustin, 100 mg / 1viala | landiolol, 280 mg / 1 viala | luspatercept, 25 mg / 1 viala | luspatercept, 75 mg / 1 viala | meropenem, 2 g / 1vial | meropenem, 1 g / 1 viala | nusinersen, 12 mg / 1 viala | nusinersen, 28 mg/ 1 viala | nusinersen, 50 mg /1 viala | piperacilin + tazobaktam, (4 g + 0,5 g) / 1 viala | ravulizumab, 1.100 mg / 1 viala | ravulizumab, 300 mg / 1 viala | risankizumab, 600 mg / 1 viala | rituksimab 70% | trabektedin, 1 mg / 1 viala | vankomicin, 1000 mg / 1 viala | vankomicin, 500 mg / 1 viala | rituksimab 30% | bevacizumab 25 mg/1ml 30%

This is one of 5 active Slovenia Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyUniverzitetni Klinični Center Ljubljana
CountrySlovenia
CategoryPharmaceuticals
Estimated value$90.8M
PublishedAugust 13, 2026
Procurement stageRequest for Proposal (RFP)
Response dueNot specified / rolling
StatusOpen — accepting responses
TranslationTranslated from Slovenian by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedOctober 04, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Slovenia

Slovenia – Pharmaceutical products – DOBAVA ZDRAVIL IZ KRVI IN KRVNIH PRIPRAVKOV
Slovenia – Pharmaceutical products – Nakup zdravil s sklenitvijo okvirnega sporazuma za obdobje enega leta
Slovenia – Medical equipments, pharmaceuticals and personal care products – NAKUP POTROŠNEGA MATERIALA ZA INTERVENTNO RADIOLOGIJO V OKVIRU DNS
Slovenia – Medical equipments, pharmaceuticals and personal care products – NAKUP POTROŠNEGA MATERIALA ZA INTERVENTNO RADIOLOGIJO V OKVIRU DNS
Slovenia – Functional support – Vzpostavitev dinamičnega nabavnega sistema za NAKUP MEDICINSKEGA VGRADNEGA MATERIALA za potrebe Univerzitetnega kliničnega centra Ljubljana
Slovenia – Pharmaceutical products – Nakup radiofarmacevtskih izdelkov in ostalega materiala za potrebe radiofarmacevtske lekarne
Slovenia – Medical equipments – Dobava medicinskega potrošnega materiala - Operacijski material - očesna klinika (POZIV 45)
Slovenia – Medical equipments – NAKUP PERKUTANIH AORTNIH ZAKLOPK V OKVIRU DINAMIČNEGA NABAVNEGA SISTEMA

See every Slovenia Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Slovenia Pharmaceuticals intelligence report in your inbox

A personalized report on Slovenia Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.